Spruce Biosciences, Inc. Operating Lease, Payments
Spruce Biosciences, Inc. (SPRB) reported Operating Lease, Payments of $354.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-09.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-03-09
- Spruce Biosciences, Inc. operating lease, payments for the quarter ending 2022-12-31 was $192.00K, a 152.63% increase year-over-year.
- Spruce Biosciences, Inc. operating lease, payments for the quarter ending 2021-12-31 was $76.00K.
- Spruce Biosciences, Inc. operating lease, payments for fiscal 2025 was $354.00K, a 2.91% increase from fiscal 2024.
- Spruce Biosciences, Inc. operating lease, payments for fiscal 2024 was $344.00K, a 37.05% increase from fiscal 2023.
- Spruce Biosciences, Inc. operating lease, payments for fiscal 2023 was $251.00K, a 48.98% decline from fiscal 2022.
- Spruce Biosciences, Inc. operating lease, payments for fiscal 2022 was $492.00K, a 30.85% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|
| 2025-12-31 | $354.00K 10-K · filed 2026-03-09 | ||
| 2024-12-31 | $344.00K 10-K · filed 2026-03-09 | ||
| 2023-12-31 | $251.00K 10-K · filed 2025-04-15 | ||
| 2022-12-31 | $192.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $492.00K 10-K · filed 2024-03-18 | |
| 2022-09-30 | $300.00K 10-Q · filed 2022-11-10 | ||
| 2021-12-31 | $76.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $376.00K 10-K · filed 2023-03-16 | |
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |